Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.68), $0.02 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.